Indefinite Delivery Contract SPE2DX15D8000

Award Date 11/13/14
Last Date to Order 11/12/25
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
Dakota Drug, Inc., a small disadvantaged business, holds an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award contract, which falls under the ECAT Generation V Program, allows Dakota Drug to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The task orders issued under this IDC indicate that Dakota Drug delivers...
The federal contract IDV award SPM20005D0979 is a single-award Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., a small disadvantaged business. The contract is set aside for total small business and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract's primary purpose is to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The awarded task...
The federal Indefinite Delivery Contract (IDC) SPE2DB24D8001 was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $999,999,999.00 single-award contract covers a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support the medical supply chain operations for the U.S. Armed Forces. The contract originates from DLA Troop Support Medical's standing solicitation SPE2DH-21-R-0002 for the ECAT...
This indefinite delivery contract (IDC) with award number SPE2DB24D8002 was awarded by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract has a ceiling value of $999,999,999.00 and a period of performance through December 31, 2025. It is a single award IDC without any set-aside designations. The contract primarily aims to procure a wide range of pharmaceutical...
The federal contract IDV award SPE2DB24D8003 was issued by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The single-award indefinite delivery contract, valued up to $999,999,999.00, covers the period of performance from June 6, 2024 to December 31, 2025. Under this contract, Dakota Drug, Inc. will provide a wide range of pharmaceutical products,...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and other federal agencies. The contract, valued at $4,999,999.00, covers a wide variety of branded and generic prescription drugs, over-the-counter medications,...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 single-award IDC, under the SPE2DB program, runs through December 31, 2025 and allows DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The IDC covers a vast array...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 single-award IDC, valid through November 30, 2026, covers a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military health facilities worldwide under the SPE2DB program. The contract scope includes branded...
The Indefinite Delivery Contract SPE2DR25D9263 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at up to $4,999,999 and has an ultimate completion date of December 31, 2036. Under this single-award IDC, DMS Pharmaceutical Group Inc. will provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare...
This single-award Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies in support of the medical needs of military healthcare facilities and veterans' medical centers nationwide. The $499,999,999 IDC, valid through November 2026, covers a diverse portfolio of branded and generic prescription...

The key products and services being delivered under this federal Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc. are a diverse range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This single-award IDC, valued at $92,841,709.00, has a performance period extending through November 12, 2025.

As a self-certified small disadvantaged business, Dakota Drug, Inc. has established itself as a critical vendor for the DLA's medical supply chain, delivering prescription medications, medical devices, vaccines, and various other healthcare-related supplies such as insulin pens, auto-injectors, inhalers, and tablet/capsule medications. The contract scope covers a wide spectrum of medical products, including antibiotics, hormone treatments, pain management medications, diabetes management supplies, respiratory medications, and immunological treatments. This IDC, identified as SPE2DX15D8000, is part of the DLA Troop Support Medical's ECAT Generation V Program and enables the efficient delivery of critical medical items to various defense healthcare facilities.

Generated 1/16/25, 9:06 AM